We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Potential Biomarker Developed for Pancreatic Cancer

By LabMedica International staff writers
Posted on 05 Jul 2012
Print article
A highly accurate, blood-based pancreatic adenocarcinoma screen has been developed that should be accurate enough to test the general population for this deadly disease.

Earlier detection of pancreatic adenocarcinoma would improve survival outcomes, but most efforts to date have been unsuccessful at identifying a biomarker or biomarker panel that has a high diagnostic sensitivity.

At the University of Utah (Salt Lake City, UT, USA) scientists have come to the conclusion that screening a panel of biomarkers might be effective by embracing the idea that pancreatic adenocarcinoma has vast genetic heterogeneity, meaning no single biomarker exists that is strongly correlated with its diagnosis across the population of people who develop the disease.

Therefore, they decided that any test for pancreatic adenocarcinoma deployed to the general population must have an accuracy of greater than 99%. To see if such levels of accuracy were possible, the investigators measured the levels of nine biomarkers of pancreatic adenocarcinoma in the blood of 117 healthy control participants, 58 participants with chronic pancreatitis and 159 patients with pancreatic adenocarcinoma. They used a statistical model, to determine that many of these weak biomarkers present in those patients with pancreatic adenocarcinoma had 95% specificity for the disease, but on average, only 32% sensitivity.

Matthew Firpo, PhD, an assistant professor at the Huntsman Cancer Institute (Salt Lake City, UT, USA) said, "Identifying 40 biomarker is reasonable. We believe we can find 40 biomarkers that are weak classifiers of the disease. That means that based on the current understanding of biomarkers that we have, there is hope for developing a panel that would have greater than 99% accuracy." He added that the next step is to identify systematically 40 to 50 biomarkers that have these characteristics giving 32% sensitivity and 95% specificity or better. The study was presented at the Cancer Research's Pancreatic Cancer: Progress and Challenges conference, held June 18-21, 2012, in Lake Tahoe (NV, USA).

Related Links:

University of Utah
Huntsman Cancer Institute



Gold Member
Chagas Disease Test
CHAGAS Cassette
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Mycoplasma Pneumoniae Virus Test
Mycoplasma Pneumoniae Virus Detection Kit
New
Centrifuge
Hematocrit Centrifuge 7511M4

Print article

Channels

Molecular Diagnostics

view channel
Image: Researcher Kanta Horie places a sample in a mass spectrometer that measures protein levels in blood plasma and other fluids (Photo courtesy of WashU Medicine)

Highly Accurate Blood Test Diagnoses Alzheimer’s and Measures Dementia Progression

Several blood tests are currently available to assist doctors in diagnosing Alzheimer's disease in individuals experiencing cognitive symptoms. However, these tests do not provide insights into the clinical... Read more

Immunology

view channel
Image: The findings were based on patients from the ADAURA clinical trial of the targeted therapy osimertinib for patients with NSCLC with EGFR-activated mutations (Photo courtesy of YSM Multimedia Team)

Post-Treatment Blood Test Could Inform Future Cancer Therapy Decisions

In the ongoing advancement of personalized medicine, a new study has provided evidence supporting the use of a tool that detects cancer-derived molecules in the blood of lung cancer patients years after... Read more

Microbiology

view channel
Image: Schematic representation illustrating the key findings of the study (Photo courtesy of UNIST)

Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours

Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.